Synthesis and Biological Evaluation of Novel Dispiro Compounds based on 5-Arylidenehydantoins and Isatins as Inhibitors of p53–MDM2 Protein–Protein Interaction
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthesis and Biological Evaluation of Novel Dispiro Compounds based on 5-Arylidenehydantoins and Isatins as Inhibitors of p53–MDM2 Protein–Protein Interaction
Authors
Keywords
-
Journal
Chemistry of Heterocyclic Compounds
Volume 56, Issue 6, Pages 747-755
Publisher
Springer Science and Business Media LLC
Online
2020-07-23
DOI
10.1007/s10593-020-02726-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis of dispirooxindoles containing N-unsubstituted heterocyclic moieties and study of their anticancer activity
- (2019) A. A. Beloglazkina et al. RUSSIAN CHEMICAL BULLETIN
- Synthesis and cytotoxicity of novel dispiro derivatives of 5-arylidenoxazolones, potential inhibitors of p53—MDM2 protein-protein interaction
- (2018) A. А. Beloglazkina et al. RUSSIAN CHEMICAL BULLETIN
- Mutant p53 as a target for cancer treatment
- (2017) Michael J. Duffy et al. EUROPEAN JOURNAL OF CANCER
- Reviving the guardian of the genome: Small molecule activators of p53
- (2017) Daniel Nguyen et al. PHARMACOLOGY & THERAPEUTICS
- Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors
- (2015) Yan A. Ivanenkov et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Triterpenoids
- (2015) Robert A. Hill et al. NATURAL PRODUCT REPORTS
- Comprehensive Review on Betulin as a Potent Anticancer Agent
- (2015) Sylwia Katarzyna Król et al. Biomed Research International
- Small-Molecule Inhibitors of the MDM2–p53 Protein–Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment
- (2014) Yujun Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drugging the p53 pathway: understanding the route to clinical efficacy
- (2014) Kian Hoe Khoo et al. NATURE REVIEWS DRUG DISCOVERY
- Development of Oleanane-Type Triterpenes as a New Class of HCV Entry Inhibitors
- (2013) Fei Yu et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Potent Small-Molecule Inhibitor of the MDM2–p53 Interaction (MI-888) Achieved Complete and Durable Tumor Regression in Mice
- (2013) Yujun Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Diastereomeric Spirooxindoles as Highly Potent and Efficacious MDM2 Inhibitors
- (2013) Yujun Zhao et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A Facile Synthesis of Functionalized Dispirooxindole Derivatives via a Three-Component 1,3-Dipolar Cycloaddition Reaction
- (2013) Jun He et al. MOLECULES
- Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization
- (2012) B. Graves et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of SREBP by a Small Molecule, Betulin, Improves Hyperlipidemia and Insulin Resistance and Reduces Atherosclerotic Plaques
- (2011) Jing-Jie Tang et al. Cell Metabolism
- Polymorphism of 5-(pyridin-2-ylmethylene)-3-phenyl-2-methylthio-3,5-dihydro-4H-imidazole-4-one
- (2011) Ilia A. Guzei et al. CRYSTENGCOMM
- Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway
- (2008) J. E. Kravchenko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A highly atom economic, chemo-, regio- and stereoselective synthesis, and discovery of spiro-pyrido-pyrrolizines and pyrrolidines as antimycobacterial agents
- (2008) Raju Ranjith Kumar et al. TETRAHEDRON
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started